Career history of Walter P. Carney
Former positions of Walter P. Carney
Companies | Position | Start | End |
---|---|---|---|
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Chief Tech/Sci/R&D Officer | 17/11/2010 | 04/04/2012 |
Corporate Officer/Principal | 04/04/2012 | 13/01/2014 | |
President | 12/09/2011 | 04/04/2012 | |
Tufts University | Corporate Officer/Principal | 31/12/1984 | - |
BioLegend CNS, Inc.
BioLegend CNS, Inc. BiotechnologyHealth Technology BioLegend CNS, Inc. provides monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative diseases. The company is headquartered in Boston, MA. | Director/Board Member | - | - |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Corporate Officer/Principal | 31/12/1998 | - |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/1996 | - |
Oncogene Science, Inc.
Oncogene Science, Inc. Medical/Nursing ServicesHealth Services Oncogene Science, Inc. provided cancer diagnostics services. The company was founded in 1983 and was headquartered in Uniondale, NY. | Chief Tech/Sci/R&D Officer | 31/12/1990 | - |
Training of Walter P. Carney
Thomas Jefferson University | Doctorate Degree |
Statistics
International
United States | 8 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Sectoral
Health Technology | 4 |
Health Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Oncogene Science, Inc.
Oncogene Science, Inc. Medical/Nursing ServicesHealth Services Oncogene Science, Inc. provided cancer diagnostics services. The company was founded in 1983 and was headquartered in Uniondale, NY. | Health Services |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
BioLegend CNS, Inc.
BioLegend CNS, Inc. BiotechnologyHealth Technology BioLegend CNS, Inc. provides monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
- Stock Market
- Insiders
- Walter P. Carney
- Experience